Choosing the best ERP for pharma is not the decision a discrete manufacturer faces. A pharmaceutical plant must prove, on demand, which raw material batches went into a given lot and which customers received it. Its audit trail has to be computer-generated, time-stamped and impossible to edit. And the system itself must be validated — IQ, OQ and PQ — before it is used for GxP work. We implement pharma ERP software on SAP S/4HANA, Oracle Fusion Cloud ERP, Microsoft Dynamics 365 and our own Xtreme Industry ERP, with the validation workstream running alongside the build.
Most ERP platforms can hold a recipe and a batch number. What makes a pharmaceutical implementation hard is that the system becomes part of your regulatory evidence. Once the ERP holds batch records, stock status decisions or release approvals, it falls inside GxP scope — and GxP scope has to be validated and kept validated, under change control, for as long as you use it.
That reshapes the programme. A discrete manufacturer goes design, build, go-live. A pharmaceutical manufacturer runs a parallel track: GxP scope assessment, validation master plan, testable user requirement specifications, a traceability matrix linking each requirement to the test that proves it, then installation, operational and performance qualification. That track is the largest single driver of cost and elapsed time — larger than the number of plants or the platform choice.
It also changes how you configure. If the audit trail must be non-editable, you cannot leave master data open to a planner who fixes a shelf-life figure on a Friday afternoon. Approval workflows, segregation of duties and restricted master data ownership become design constraints.
On platform choice: if you export to the US or the EU, the validation burden and process-industry depth both favour a platform with an established pharmaceutical track record — SAP S/4HANA with its process industry functionality, or Oracle Fusion Cloud ERP. A domestic-only manufacturer has more freedom, and Dynamics 365 or Xtreme Industry ERP can be the better economic answer. We implement all four.
Each is configured against your own processes, products and markets, then evidenced in the qualification protocols. Delivered under our CMMI Level 3 appraised framework and ISO 27001 certified security.
Genealogy is a regulatory obligation, not a reporting nicety. The system must answer both directions: which lots went into this batch, and which customers received it.
Part 11 and Annex 11 govern electronic records and signatures. The controls are mostly configuration and procedure rather than code, but must be designed in and demonstrated.
Validation is what separates a pharma ERP implementation from any other. We build it as a deliverable set, not paperwork at the end.
Pharma is process manufacturing. Formulations behave differently from a bill of materials, and inventory is not fungible by quantity alone.
Stock is defined by its dates and status, not its item code alone. Allocation logic that ignores that quietly writes off working capital.
Quality decisions and stock movements belong in one place. Otherwise the ledger, the warehouse and the quality file tell three different stories.
Serialisation is a market-access requirement. The ERP must generate or consume serial numbers, hold aggregation and report in each market's format.
| Dimension | Domestic market only | Regulated export (US / EU) |
|---|---|---|
| Validation scope | Scope assessment still required; qualification often risk-reduced on lower-impact modules | Full IQ/OQ/PQ across GxP scope, with validation master plan and traceability matrix held for inspection |
| Serialisation | Generally not required unless a customer or tender demands it | Mandatory: US DSCSA, EU FMD, plus DGFT and iVEDA reporting for Indian exporters |
| Batch release | By the authorised quality head against defined specifications | By a Qualified Person for EU supply, with a distinct signature step and market-specific checks |
| Platform freedom | Wider: Dynamics 365 or Xtreme Industry ERP often the better economic fit | Narrower: validation burden and process-industry depth favour SAP S/4HANA or Oracle Fusion Cloud ERP |
A planning view, not regulatory advice. MJC GlobalTech implements and validates ERP systems; we do not issue regulatory approvals or sign off a compliance position. Your quality unit owns the GxP decisions.
Build and validation run together. Each qualification stage produces an approved protocol and report before the next begins.
We walk your processes with your quality unit and decide, in writing, which modules, interfaces and records are GxP-relevant. Effort, cost and timeline follow from this boundary, so it is settled first.
A validation master plan, a system risk assessment, and user requirement specifications written to be testable. Vague requirements are why OQ scripts get rewritten halfway through.
Formulations, batch numbering, status management, FEFO rules and Part 11 settings configured, then IQ evidencing that environments, versions and interfaces match specification.
Scripted OQ against the URS — audit trail immutability, signature behaviour, status transitions, expiry logic, role restrictions — alongside migration of formulations, open batches, batch history and dated stock, reconciled record by record. Migrated genealogy is verified, not assumed.
PQ with your own products and people: a timed mock recall in both directions, and a batch release dry run through the Qualified Person's signature.
Cutover scheduled around your batch calendar, then the system enters your change control and periodic review cycle, with revalidation support on significant changes.
Whether it's setting up your India GCC, modernizing your enterprise stack, or hiring 50 engineers in 30 days — we'd love to scope it with you.
